Hepatitis Monthly

Published by: Kowsar

The Frequency of HBsAg in Pregnant Women from Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis

Pooneh Malekifar 1 , Mehran Babanejad 2 , Neda Izadi 3 and Seyed Moayed Alavian 4 , *
Authors Information
1 Department of Epidemiology, Research Student Committee, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Social Development and Health Promotion Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 Research Student Committee, School of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
4 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran
Article information
  • Hepatitis Monthly: September 2018, 18 (9); e58830
  • Published Online: August 18, 2018
  • Article Type: Review Article
  • Received: July 26, 2017
  • Revised: July 20, 2018
  • Accepted: July 21, 2018
  • DOI: 10.5812/hepatmon.58830

To Cite: Malekifar P, Babanejad M, Izadi N, Alavian S M. The Frequency of HBsAg in Pregnant Women from Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis, Hepat Mon. 2018 ; 18(9):e58830. doi: 10.5812/hepatmon.58830.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Method
3. Results
4. Discussion
  • 1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337(24):1733-45. doi: 10.1056/NEJM199712113372406. [PubMed: 9392700].
  • 2. Previsani NLD. Hepatitis B. WHO/CDS/CSR/LYO/ 2002. 2: Hepatitis B. 2002.
  • 3. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009;29 Suppl 1:133-9. doi: 10.1111/j.1478-3231.2008.01933.x. [PubMed: 19207977].
  • 4. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97-107. doi: 10.1046/j.1365-2893.2003.00487.x. [PubMed: 14996343].
  • 5. Sinha S, Kumar M. Pregnancy and chronic hepatitis B virus infection. Hepatol Res. 2010;40(1):31-48. doi: 10.1111/j.1872-034X.2009.00597.x. [PubMed: 20156298].
  • 6. Ghosh M, Nandi S, Dutta S, Saha MK. Detection of hepatitis B virus infection: A systematic review. World J Hepatol. 2015;7(23):2482-91. doi: 10.4254/wjh.v7.i23.2482. [PubMed: 26483870]. [PubMed Central: PMC4606204].
  • 7. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976;294(14):746-9. doi: 10.1056/NEJM197604012941402. [PubMed: 943694].
  • 8. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105(2):94-8. [PubMed: 835566].
  • 9. Xu ZY, Liu CB, Francis DP, Purcell RH, Gun ZL, Duan SC, et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics. 1985;76(5):713-8. [PubMed: 3903646].
  • 10. Stevens CE, Toy PT, Tong MJ, Taylor PE, Vyas GN, Nair PV, et al. Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA. 1985;253(12):1740-5. doi: 10.1001/jama.253.12.1740. [PubMed: 3974052].
  • 11. World Health Organization . Prevention and control of viral hepatitis infection: framework for global action. 2012. Geneva: World Health Organization; 2015.
  • 12. World Health Organization . Hepatitis B vaccines. Wkly Epidemiol Rec. 2009;84(40):405-19. [PubMed: 19817017].
  • 13. Borgia G, Carleo MA, Gaeta GB, Gentile I. Hepatitis B in pregnancy. World J Gastroenterol. 2012;18(34):4677-83. doi: 10.3748/wjg.v18.i34.4677. [PubMed: 23002336]. [PubMed Central: PMC3442205].
  • 14. Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol. 2011;55(6):1215-21. doi: 10.1016/j.jhep.2011.02.032. [PubMed: 21703206].
  • 15. World Health Organization . The growing threats of hepatitis B and C in the Eastern Mediterranean Region: a call for action. 2009. Available from: http://applications.emro.who.int/docs/EM_RC56_3_en.pdf.
  • 16. World Health Organization . Hepatitis B. 2015. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.
  • 17. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010;14(1):1-21. vii. doi: 10.1016/j.cld.2009.11.009. [PubMed: 20123436].
  • 18. Alavian SM. Ministry of Health in Iran is serious about controlling hepatitis B. Hepat Mon. 2007;7(1):3-5.
  • 19. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B virus infection in Iran: A systematic review. Hepat Mon. 2008;8(4):281-94.
  • 20. Moghaddasifar I, B. Lankarani K, Moosazadeh M, Afshari M, Malary M. Prevalence of hepatitis B virus infection among pregnant women in Iran: A systematic review and meta-analysis. Iran J Cancer Prev. 2016;9(6). doi: 10.17795/ijcp-3703.
  • 21. Abo-Salem MES, Mahrous OAE, El-Shaarawy AA, Mohamed HM, Yehia SAS. Seroprevalence of hepatitis B among pregnant women attending maternal and child health centres in Shebin El-Kom district (Menoufia governorate). Menoufia Med J. 2014;27(4):847-52. doi: 10.4103/1110-2098.149805.
  • 22. Aynioglu A, Aynioglu Ö, Tarik A, Aydin M, Altunok ES. HBsAg, Anti-HBs and Anti-HCV seropositivity rates among pregnant women Attending a University Hospital in Zonguldak. Viral Heoat J. 2015;21(1):31-4. doi: 10.4274/vhd.73792.
  • 23. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72(1):39. doi: 10.1186/2049-3258-72-39. [PubMed: 25810908]. [PubMed Central: PMC4373114].
  • 24. Altinbas S, Erdogan M, Danisman N. The seroprevalences of HBs Ag and anti-HCV in pregnant women in Ankara. Arch Gynecol Obstet. 2010;281(2):371. doi: 10.1007/s00404-009-1145-6. [PubMed: 19521710].
  • 25. Araz NC, Dikensoy E. Seroprevalence of hepatitis B among pregnant women in southern Turkey. J Pak Med Assoc. 2011;61(2):176-7. [PubMed: 21375171].
  • 26. Ahmad I. Prevalence of hepatitis B and C viral infection among pregnant women in Peshawar, Pakistan. Hepat Mon. 2016;16(6). e36383. doi: 10.5812/hepatmon.36383. [PubMed: 27630725]. [PubMed Central: PMC5011400].
  • 27. Yavuz U, Cevat C, Alaaddin B. Seroprevalence of hepatitis B virus among pregnant women in Northern Turkey. Hepat Mon. 2009;9(2):146-9.
  • 28. Ghanghro AA, Ghanghro L. High prevalence of hepatitis C and hepatitis B infection among pregnant women and their blood donors District Naushahro Feroze, Pakistan 2014. J Emerg Med Trauma Acute Care. 2016;2016(2):32. doi: 10.5339/jemtac.2016.icepq.32.
  • 29. Zahran KM, Badary MS, Agban MN, Abdel Aziz NH. Pattern of hepatitis virus infection among pregnant women and their newborns at the Women's Health Center of Assiut University, Upper Egypt. Int J Gynaecol Obstet. 2010;111(2):171-4. doi: 10.1016/j.ijgo.2010.06.013. [PubMed: 20708181].
  • 30. Afzali H, Momen Heravi M, Moravveji SA, Poorrahnama M. Prevalence of hepatitis B surface antigen in pregnant women in Beheshti Hospital of Kashan, Isfahan. Iran Red Crescent Med J. 2015;17(7). e20598. doi: 10.5812/ircmj.20598v2. [PubMed: 26421168]. [PubMed Central: PMC4584256].
  • 31. Ahmadi M, Toghyani R, Shahidi S, Izadi M, Merasi MR, Agdak P, et al. Prevalence of HBsAg and high-risk behaviors in pregnant women rerring to Urban Health Centers in Isfahan province. Iran J Nurs Midwifery Res. 2011;16(1):47-54. [PubMed: 22039379]. [PubMed Central: PMC3203299].
  • 32. Aminzadeh Z, Gachkar L, Sayyadi Anari AR. [Frequency of HBsAg positive in pregnant women Rafsanjan in the year 2003]. Journal of Rafsanjan University of Medical Sciences. 2004;3(2):126-33. Persian.
  • 33. Bayani M, Biazar T, Bayani F, Siadati S. The effect of hepatitis B vaccination at birth on reducing the prevalence of hepatitis B surface antigen among rural pregnant women in Babol, Iran. J Babol Univ Med Sci. 2016;18(1):7-10.
  • 34. Cheraghali F, Yazarloo S, Behnampour N, Azarhoush R. Frequency of HBsAg in pregnant women in Gorgan, Iran. J Gorgan Univ Med Sci. 2011;12(4).
  • 35. Kavosi A, Vizvari P, Mohammadi G, Jouybari L, Sanagu A. [Seroprevalence of positive HbsAg and its associated factors in pregnant women referred to health centers of Agh-Ghala city in 2010-2012]. Iran J Obstet Gynecol Infertil. 2015;18(149):8-16. Persian.
  • 36. Kheiri L, Makvandi S. The prevalence of hepatitis B surface antigen (HBsAg) and its influencing factors in pregnant women referring to Healthcare Centers of Dehloran, Iran in 2011-2012. J Midwifery Reprod Health. 2015;3(3):424-9.
  • 37. Mirghaforvand M, Rafie A, Montazam SH. [Study of prevalence and contributing factors of hepatitis B among pregnant women referred to laboratory of health center of Bonab]. J Urmia Nurs Midwifery Fac. 2007;5(3):120-31. Persian.
  • 38. Mobin AR, Mohammadian F, Mazloomzadeh S, Esmaeilzadeh A, Sorouri Zanjani R, Savabi S, Soleimanipor S, et al. [Seroprevalence of Hepatitis B virus among pregnant women referred to healthcare centers of Zanjan]. Zanjan Univ Mes Sci J. 2014;22(93):96-104. Persian.
  • 39. Mohamad Jafari R, Saadati N, Vaziri S, Soranian A. [Frequencey of positive HBsAg cases in pregnant women referred to health centers of Ahvaz]. Payesh Q. 2004;3(3):237-43. Persian.
  • 40. Mohebbi SR, Sanati A, Cheraghipour K, Rostami Nejad M, Shalmani HM, Zali MR. Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran. Hepat Mon. 2011;11(9):736-9. doi: 10.5812/kowsar.1735143X.749. [PubMed: 22235217]. [PubMed Central: PMC3234534].
  • 41. Motamedifar M, Amini E, Talezadeh Shirazi P, Sarvari J. The prevalence of HBsAg and HBsAb among pregnant women re-ferring to Zeinabiyeh Hospital, Shiraz Iran. Shiraz E Med J. 2012;13(4):187-96.
  • 42. Motazakker M, Shokat Nagadeh M, Khalili F, Shayeri B. [Hepatitis B virus infection among pregnant women attending health care centers of Urmia]. J Uilan Univ Med Sci. 2014;23(89):45-50. Persian.
  • 43. Sahaf F, Tanomand A, Montazam H, Sany A. Seroprevalence of hepatitis C, hepatitis B and HIV and co-infection among pregnant women: A retrospective study in 2006 at Malekan city, Iran. Res J Med Sci. 2007;1(2):138-41.
  • 44. Salimi S, Alijahan R, Nakhostin B, Hazrati S. [Prevalence of HbsAg+ cases and its associated factors in pregnant women referred to health centers of ardabil district in 2009]. J Health. 2014;5(3):248-58. Persian.
  • 45. Sharifi Mood B, Keykhah F, Sanei Moghadam E, Salehi M, Kohpayeh HR, Alavi Nayini R, et al. Prevalence of hepatitis B surface antigen in pregnant women in Zahedan, Iran. Hepat Mon. 2004;4(8):161.
  • 46. Sharifi M, Asefzade M, Lalouha F, Alipour HM, Eshtiagh B. [Prevalence of HBsAg carriers in pregnant women in Qazvin (2000-2001)]. J Qazvin Univ Med Sci. 2006;10(38):72-8. Persian.
  • 47. Shoghli A, Nabavi SM, Alavian SM, Kolifarhood G, Goya MM, Namazi R, et al. Hepatitis B surface antigen prevalence in pregnant women: A cross-sectional survey in Iran. Int J Prev Med. 2014;5(Suppl 3):S213-8. [PubMed: 26622992]. [PubMed Central: PMC4635415].
  • 48. Tabasi Z, Mir Hosseini F, Mousavi SGA, Ghafouri L. [HBsAg in parturients referring to gynecologic clinics in Kashan, 2002]. Feyz. 2003;7(3):35-41. Persian.
  • 49. Mojibian M, Sharifi MR, Behjati AR. [The prevalence rate of hepatitis b surface antigene (hbsag) carrier in pregnant women referred to prenatal care centers in Yazd]. J Shahid Sadoughi Univ Med Sci Health Serv. 2001;9(2):34-8. Persian.
  • 50. Batayneh N, Bdour S. Risk of perinatal transmission of hepatitis B virus in Jordan. Infect Dis Obstet Gynecol. 2002;10(3):127-32. doi: 10.1155/S1064744902000121. [PubMed: 12625968]. [PubMed Central: PMC1784612].
  • 51. El-Magrahe H, Furarah AR, El-Figih K, El-Urshfany S, Ghenghesh KS. Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Tripoli, Libya. J Infect Dev Ctries. 2010;4(3):168-70. [PubMed: 20351458].
  • 52. Al Awaidy S, Abu-Elyazeed R, Al Hosani H, Al Mulla A, Al Busaiedy S, Al Amiry A, et al. Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. J Infect. 2006;52(3):202-6. doi: 10.1016/j.jinf.2005.05.006. [PubMed: 16271396].
  • 53. Sabir R, Osmani ON, Mahboob T. Frequency of HBs Ag and Anti-HCV in antenatal population. J Univ Med Dent College. 2013;4(2):34-41.
  • 54. Asia B, Bano K, Misba IK, Riaz H. Antenatal screening of women for hepatitis B and C in an out-patient department. J Dow Univ Health Sci. 2008;2(1):32-5.
  • 55. Mehnaz A, Syed S, Hasmi H. Hepatitis B markers in mothers and its transmission in newborn. J Coll Physicians Surg Pak. 2002;12(4):240-2.
  • 56. Bani I, Mahfouz MS, Gaffar EMA, Elhassan I, Yassin AO, Ageely HM. Prevalence and risk factors of hepatitis B virus among pregnant women in Jazan Region-Kingdom of Saudi Arabia. J Biol Agric Healthcare. 2012;2(8).
  • 57. Khalil MK, Al-Mazrou YY, Al-Jeffri M, Al-Ghamdi YS, Mishkhas A, Bakhsh M, et al. Serosurvey of hepatitis B surface antigen in pregnant Saudi women. East Mediterr Health J. 2005;11(4):640-7. [PubMed: 16700379].
  • 58. Alrowaily MA, Abolfotouh MA, Ferwanah MS. Hepatitis B virus sero-prevalence among pregnant females in Saudi Arabia. Saudi J Gastroenterol. 2008;14(2):70-2. doi: 10.4103/1319-3767.39621. [PubMed: 19568503]. [PubMed Central: PMC2702893].
  • 59. Abuelgasim MH, Baraka MBK. Prevalence of hepatitis B infection among PreGNANT WOMEN at Khartoum Teaching Hospital, Sudan. J US-China Med Sci. 2015;12:58-63.
  • 60. Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J. 2007;4:104. doi: 10.1186/1743-422X-4-104. [PubMed: 17958904]. [PubMed Central: PMC2116999].
  • 61. Osman AMM, Minrghani OA, Gasim GI, Adam I. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection among pregnant women in Central Sudan. Sudanese J Med Sci. 2014;9(2):91-5.
  • 62. Hannachi N, Bahri O, Mhalla S, Marzouk M, Sadraoui A, Belguith A, et al. [Hepatitis B virus infection in Tunisian pregnant women: risk factors and viral DNA levels in HBe antigen negative women]. Pathol Biol (Paris). 2009;57(3):e43-7. French. French. doi: 10.1016/j.patbio.2008.04.017. [PubMed: 18513893].
  • 63. Balık G, Üstüner I, Kağıtcı M, Ural UM, Tekin YB, Şentürk S. HBsAg, AntiHBs and Anti-HCV seroprevalance in pregnant women living in Rize region. Dicle Med J. 2013;40(2):254-7. doi: 10.5798/diclemedj.0921.2013.02.0265.
  • 64. Deveci O. Investigation of intrauterine transmission of Hepatitis B Virus to children from HBsAg-positive pregnant women. J Microbiol Infect Dis. 2011;1(1):14-6. doi: 10.5799/ahinjs.02.2011.01.0004.
  • 65. Dogan K, Guraslan H, Ozel G, Aydan Z, Yasar L. [Seroprevalence rates of Toxoplasma gondii, rubella, cytomegalovirus, syphilis, and hepatitis B, seroprevalences rate in the pregnant population in Istanbul]. Turkiye Parazitol Derg. 2014;38(4):228-33. Turkish. Turkish. doi: 10.5152/tpd.2014.3435. [PubMed: 25732880].
  • 66. Gönen I. The frequency of HBV and HCV in pregnant women in rural areas. Viral Hepat Dergisis. 2011;17(2).
  • 67. Guckan R, Kilinc C, Gozdemir E. HBSAG, Anti Hbs, Anti -HCV and Anti -HIV seroplevalence in pregnant women living. Asian Pac J Nurs. 2016;3(1):9-12.
  • 68. Karaca Ç, Karaca N, Usta T. The frequencies of Hepatitis B, C, D virus infection in the pregnant population and the rate of perinatal transmission of Hepatitis C virus. Akademik Gastroenteroloji Dergisi. 2003;2:122-4.
  • 69. Evirgen Ö, Aksakal M, Melek I, Önlem Y, Sabahattin O. Seropositivity of hepatitis B and hepatitis C in women who were admitted to Hatay Maternityand Children's Hospital. Viral Hepat Dergisis. 2010;16(2).
  • 70. Tosun SY, Erensoy S, Özacar T, Yücebilgin S, Bilgiç A. The investigation and follow-up of pregnant women and their children for hepatitis virus infections. Türk Mikrobiyol Cem Derg. 2003;33:153-9.
  • 71. Yavuzcan A, Altınbas, A , Altınbas, S . An unexpected low Hepatitis B seroprevalence in pregnant women from the rural Southeastern Turkey. Afr J Microbiol Res. 2011;5(23):3942-5. doi: 10.5897/ajmr11.675.
  • 72. Furuncuoglu Y, Bolukbas FF, Bolukbas C, Torun P, Ozturk R. Changes in the prevalence of HBV infection in pregnant women in Turkey between 1995 and 2015: a 20-year evaluation. Postgrad Med J. 2016;92(1091):510-3. doi: 10.1136/postgradmedj-2015-133876. [PubMed: 26941270].
  • 73. Murad EA, Babiker SM, Gasim GI, Rayis DA, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Sana'a, Yemen. BMC Pregnancy Childbirth. 2013;13:127. doi: 10.1186/1471-2393-13-127. [PubMed: 23758990]. [PubMed Central: PMC3684507].
  • 74. Ramos JM, Toro C, Reyes F, Amor A, Gutierrez F. Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia. J Clin Virol. 2011;51(1):83-5. doi: 10.1016/j.jcv.2011.01.010. [PubMed: 21330196].
  • 75. Harry TO, Bajani MD, Moses AE. Hepatitis B virus infection among blood donors and pregnant women in Maiduguri, Nigeria. East Afr Med J. 1994;71(9):596-7. [PubMed: 7875094].
  • 76. Ugbebor O, Aigbirior M, Osazuwa F, Enabudoso E, Zabayo O. The prevalence of hepatitis B and C viral infections among pregnant women. N Am J Med Sci. 2011;3(5):238-41. doi: 10.4297/najms.2011.3238. [PubMed: 22558601]. [PubMed Central: PMC3337744].
  • 77. Lin CC, Hsieh HS, Huang YJ, Huang YL, Ku MK, Hung HC. Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries. BMC Public Health. 2008;8:49. doi: 10.1186/1471-2458-8-49. [PubMed: 18254978]. [PubMed Central: PMC2275262].
  • 78. Ding Y, Sheng Q, Ma L, Dou X. Chronic HBV infection among pregnant women and their infants in Shenyang, China. Virol J. 2013;10:17. doi: 10.1186/1743-422X-10-17. [PubMed: 23294983]. [PubMed Central: PMC3568011].
  • 79. Lobstein S, Faber R, Tillmann HL. Prevalence of hepatitis B among pregnant women and its impact on pregnancy and newborn complications at a tertiary hospital in the eastern part of Germany. Digestion. 2011;83(1-2):76-82. doi: 10.1159/000320455. [PubMed: 21042018].
  • 80. Denis F, Ranger-Rogez S, Alain S, Mounier M, Debrock C, Wagner A, et al. Screening of pregnant women for hepatitis B markers in a French Provincial University Hospital (Limoges) during 15 years. Eur J Epidemiol. 2004;19(10):973-8. doi: 10.1007/s10654-004-5755-9. [PubMed: 15575357].
  • 81. Anderson SR, Righarts A, Maguire H. Surveillance of antenatal infections--HIV, hepatitis B, syphilis and rubella susceptibility in London. Commun Dis Public Health. 2004;7(4):251-7. [PubMed: 15779784].
  • 82. World Health Organization . Hepatitis B. 2017. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.
  • 83. Center for Diseas Contral and Prevention . Perinatal Transmission. 2017. Available from: https://www.cdc.gov/hepatitis/hbv/perinatalxmtn.htm.
  • 84. Mast E, Mahoney F, Kane M, Margolis H. Hepatitis B vaccine. Vaccines Philadelphia: Saunders; 2004. p. 299-37.
  • 85. Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis. 2003;187(1):134-8. doi: 10.1086/345871. [PubMed: 12508157].
  • 86. Lee CL, Ko YC. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics. 1997;99(3):351-3. doi: 10.1542/peds.99.3.351. [PubMed: 9041286].
  • 87. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336(26):1855-9. doi: 10.1056/NEJM199706263362602. [PubMed: 9197213].
  • 88. Choe JH, Taylor VM, Yasui Y, Burke N, Nguyen T, Acorda E, et al. Health care access and sociodemographic factors associated with hepatitis B testing in Vietnamese American men. J Immigr Minor Health. 2006;8(3):193-201. doi: 10.1007/s10903-006-9322-1. [PubMed: 16791529].
  • 89. Taylor VM, Jackson JC, Chan N, Kuniyuki A, Yasui Y. Hepatitis B knowledge and practices among Cambodian American women in Seattle, Washington. J Community Health. 2002;27(3):151-63. [PubMed: 12027266]. [PubMed Central: PMC1592329].
  • 90. Centers for Disease C; Prevention. Screening for chronic hepatitis B among Asian/Pacific Islander populations--New York City, 2005. MMWR Morb Mortal Wkly Rep. 2006;55(18):505-9. [PubMed: 16691180].
  • 91. Hamdani-Belghiti S, Bouazzaou NL. [Mother-child transmission of hepatitis B virus. State of the problem and prevention]. Arch Pediatr. 2000;7(8):879-82. French. French. doi: 10.1016/S0929-693X(00)80199-2. [PubMed: 10985190].
  • 92. Lin K, Vickery J. Screening for hepatitis B virus infection in pregnant women: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009;150(12):874-6. [PubMed: 19528566].
  • 93. Gambarin-Gelwan M. Hepatitis B in pregnancy. Clin Liver Dis. 2007;11(4):945-63. x. doi: 10.1016/j.cld.2007.08.004. [PubMed: 17981236].
  • 94. Yogeswaran K, Fung SK. Chronic hepatitis B in pregnancy: unique challenges and opportunities. Korean J Hepatol. 2011;17(1):1-8. doi: 10.3350/kjhep.2011.17.1.1. [PubMed: 21494071]. [PubMed Central: PMC3304622].
  • 95. Brown RS Jr, McMahon BJ, Lok AS, Wong JB, Ahmed AT, Mouchli MA, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatology. 2016;63(1):319-33. doi: 10.1002/hep.28302. [PubMed: 26565396].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments